Back to Search
Start Over
Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China.
- Source :
-
World journal of surgical oncology [World J Surg Oncol] 2015 Dec 08; Vol. 13, pp. 332. Date of Electronic Publication: 2015 Dec 08. - Publication Year :
- 2015
-
Abstract
- Background: The aim of this study is to evaluate the safety and efficacy of bursectomy of D2 gastrectomy in terms of postoperative complications and short-term survival outcomes.<br />Methods: From January 2012 to December 2013, data of 406 gastric cancer patients with advanced tumor stages and who underwent D2 radical gastrectomy and were grouped according to whether bursectomy was performed or not in West China Hospital, Sichuan University, were analyzed.<br />Results: Finally, 159 patients were in bursectomy group and 247 patients in non-bursectomy group. Surgical duration was 260.1 ± 43.4 min in the bursectomy group, compared to 227.9 ± 48.6 min in the non-bursectomy group (p < 0.001). The intraoperative blood loss was comparable between the bursectomy group and the non-bursectomy group (198.9 ± 63.5 vs. 201.1 ± 53.7 ml, p = 0.729). Postoperative morbidity rate showed no significant difference between the two groups, which were 23.3 % in the bursectomy group and 17.8 % in the non-bursectomy group, p = 0.179. The overall survival outcomes of patients were compared between the two groups of all patients (p = 0.055): patients who underwent distal gastrectomy (p = 0.129) and total gastrectomy (p = 0.016) and pT2-3 stage patients (p = 0.117) and pT4a stage patients (p = 0.128). The multivariate survival analysis identified that bursectomy or not, pT stage and pN stage were independent prognostic risk factors for the overall survival.<br />Conclusions: The bursectomy might increase the surgical duration when the D2 gastrectomy was done. Experienced surgeons can perform it safely. However, for the survival benefits of bursectomy, long-term, large sample sized, and high-quality randomized controlled trials are expected.
- Subjects :
- Adenocarcinoma mortality
Adult
Aged
China
Female
Humans
Male
Middle Aged
Neoplasm Staging
Retrospective Studies
Stomach Neoplasms mortality
Treatment Outcome
Adenocarcinoma pathology
Adenocarcinoma surgery
Gastrectomy
Peritoneal Cavity surgery
Stomach Neoplasms pathology
Stomach Neoplasms surgery
Subjects
Details
- Language :
- English
- ISSN :
- 1477-7819
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- World journal of surgical oncology
- Publication Type :
- Academic Journal
- Accession number :
- 26643472
- Full Text :
- https://doi.org/10.1186/s12957-015-0744-x